Pravastatin Therapy and the Risk of Stroke

2000337 citationsJournal Articlebronze Open Access

Authors

Harvey D. White · Greenlane Clinical Centre

R. John Simes · National Health and Medical Research Council

Neil E. Anderson · University of Auckland

Graeme J. Hankey · The University of Sydney

J D Watson

David Hunt · The University of Sydney

David Colquhoun · Wesley Research Institute

Abstract

Pravastatin has a moderate effect in reducing the risk of stroke from any cause and the risk of nonhemorrhagic stroke in patients with previous myocardial infarction or unstable angina.

Topics & Keywords

Lipoproteins and Cardiovascular Health Cancer, Lipids, and Metabolism Diabetes, Cardiovascular Risks, and Lipoproteins

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 343, Issue 5, pp. 317-326

DOI: 10.1056/nejm200008033430502

Field-Weighted Citation Impact: 41.43